by GlobeNewswireCanada | Jan 11, 2016 | Globe Newswire Canada, GNW Alerts
BURNABY, British Columbia, Jan. 11, 2016 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today outlined its anticipated key corporate milestones for 2016.Dr. Simon Pimstone, Xenon’s President and Chief...
by editor | Jan 4, 2016 | Blog
NOTE: This company now trades as GeneSYS ID, Inc. (OTCQB: GNID). .. Introduces Initial Growth Plans for 2016 HENDERSON, NV–(Marketwired – Jan 4, 2016) -Rx Safes, Inc. (OTCQB: RXSF) the developer of autonomous fingerprint healthcare security products...